Cargando…
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC
BACKGROUND: Coronavirus disease 2019 (COVID‐19) is a highly contagious respiratory disease that has posed a serious threat to people’s daily lives and caused an unprecedented challenge to public health and people’s health worldwide. Lung squamous cell carcinoma (LUSC) is a common type of lung malign...
Autores principales: | Wu, Wen-yu, Jiao, Xin, Song, Wen-xin, Wu, Peng, Xiao, Pei-qi, Huang, Xiu-fang, Wang, Kai, Zhan, Shao-feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281056/ https://www.ncbi.nlm.nih.gov/pubmed/37347115 http://dx.doi.org/10.3389/fendo.2023.1187882 |
Ejemplares similares
-
Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19
por: Zhang, Wentao, et al.
Publicado: (2022) -
NF-YA Overexpression in Lung Cancer: LUSC
por: Bezzecchi, Eugenia, et al.
Publicado: (2019) -
Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers
por: Chen, Mengzhu, et al.
Publicado: (2016) -
Melanocortin-4 Receptor in Spotted Sea Bass, Lateolabrax maculatus: Cloning, Tissue Distribution, Physiology, and Pharmacology
por: Zhang, Kai-Qiang, et al.
Publicado: (2019) -
Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes
por: Wu, Ming, et al.
Publicado: (2022)